Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
…, H Furukawa, S Yoshino, M Yukioka, S Tohma… - Nature …, 2003 - nature.com
Individuals with rheumatoid arthritis frequently have autoantibodies to citrullinated peptides,
suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (…
suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (…
Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis
…, H Yanagida, H Furukawa, S Tohma… - Annals of the …, 2017 - ard.bmj.com
Objectives Systemic sclerosis (SSc) is an autoimmune disease characterised by skin and
systemic fibrosis culminating in organ damage. Previous genetic studies including genome-…
systemic fibrosis culminating in organ damage. Previous genetic studies including genome-…
[HTML][HTML] MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
…, S Ottaviani, S Oka, S Tohma… - … England Journal of …, 2018 - Mass Medical Soc
Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …
interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population
…, T Matsubara, S Wakitani, R Teshima, S Tohma… - Nature …, 2012 - nature.com
Rheumatoid arthritis is a common autoimmune disease characterized by chronic inflammation.
We report a meta-analysis of genome-wide association studies (GWAS) in a Japanese …
We report a meta-analysis of genome-wide association studies (GWAS) in a Japanese …
Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using …
…, M Yasuda, K Saisho, K Shimada, S Tohma - Annals of the …, 2007 - ard.bmj.com
Objectives: To compare disease activity and the improvement of disease activity evaluated
between by Disease Activity Score 28 using erythrocyte sedimentation rate (DAS28-ESR) …
between by Disease Activity Score 28 using erythrocyte sedimentation rate (DAS28-ESR) …
Current treatments of rheumatoid arthritis: from the 'NinJa'registry
…, T Matsui, K Saisho, S Tohma - Expert Review of Clinical …, 2012 - Taylor & Francis
In this review, recent changes in both treatments and outcomes of rheumatoid arthritis (RA)
in Japan were analyzed by viewing the National Database of Rheumatic Diseases by iR-net, …
in Japan were analyzed by viewing the National Database of Rheumatic Diseases by iR-net, …
[HTML][HTML] Growth retardation in mice lacking the proteasome activator PA28γ
S Murata, H Kawahara, S Tohma, K Yamamoto… - Journal of Biological …, 1999 - ASBMB
The proteasome activator PA28 binds to both ends of the central catalytic machine, known as
the 20 S proteasome, in opposite orientations to form the enzymatically active proteasome. …
the 20 S proteasome, in opposite orientations to form the enzymatically active proteasome. …
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese …
Objective. To compare tumor necrosis factor-α (TNF-α) inhibitors to nonbiological disease-modifying
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …
[PDF][PDF] Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis
…, M Kondo, Y Ueki, M Iwahashi, S Tohma… - Arthritis care & …, 2014 - Wiley Online Library
Objective To evaluate the efficacious noninferiority of subcutaneous tocilizumab injection (TCZ‐SC)
monotherapy to intravenous TCZ infusion (TCZ‐IV) monotherapy in Japanese …
monotherapy to intravenous TCZ infusion (TCZ‐IV) monotherapy in Japanese …
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study
…, H Sano, K Takasugi, T Takeuchi, S Tohma… - Modern …, 2014 - Taylor & Francis
Objectives To investigate the duration of remission and low disease activity (LDA) after cessation
of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or …
of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or …